Please login to the form below

Not currently logged in
Email:
Password:

Edelman acquires Dutch health PR firm

New York City-based Edelman has acquired the Dutch firm Hinfelaar PR, Life & Health Communications

New York City-based Edelman has acquired the Dutch firm Hinfelaar PR, Life & Health Communications, whose current clients include Boehringer Ingelheim, MerckSerono and Astellas. The agency, which is made up of seven professionals, also supports several of Edelman's healthcare clients, including AstraZeneca, Novartis, Pfizer and Wyeth.

The Dutch firm, which specialises in health and food communications, was founded in 1998 by Marc Hinfelaar, who will now join Edelman Amsterdam's management team and will lead the combined consumer, health and food teams at the Dutch offices in Amsterdam and Baarn. Before founding the company, Hinfelaar was a partner and senior consultant at the PR firm Forman Grayling B.V. and, earlier in his career, a corporate PR officer at Solvay Pharmaceuticals.

Edelman's Netherlands business, which is headquartered in Amsterdam, employs 50 professionals and has annual revenues of about €4.2m.

The purchase of Hinfelaar is the latest in a string of acquisitions for Edelman. Last month, the company acquired the Brazilian branding and PR firm Significa and the Texas-based PR firm Vollmer, whose clients include the American Heart Association and the National Multiple Sclerosis Society.

8th October 2010

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics